Science
Francesco Massari: Excited to See Our ARON Research Published in Nature Communications
Francesco Massari/ X, Matteo Santoni/ X and Tarek Taha/ LinkedIn

Francesco Massari: Excited to See Our ARON Research Published in Nature Communications

Francesco Massari, Medical Oncologist focused on Genitourinary Cancer at The University Hospital of Bologna IRCCS, shared on X:

“It is exciting to see our ARON project on Sex-based differences in clinical outcomes of enfortumab vedotin and NECTIN-4 expression in urothelial cancer published on Nature Communications.

Thanks to Tarek Taha, Matteo Santoni and all my Aron friends.”

Title: Sex-based differences in clinical outcomes of enfortumab vedotin and NECTIN-4 expression in urothelial cancer

Authors: Tarek Taha, Ayelet Alpert, Jalal Baranseh, Alessandro Rizzo, Francesco Ciccimarra, Enrique Grande, Joaquim Bellmunt, Sebastiano Buti, Francesco Massari, Shilpa Gupta, Fernando Sabino Marques Monteiro, Ravindran Kanesvaran, Giandomenico Roviello, Cristian Lolli, Yüksel Ürün, Hideki Takeshita, Avivit Peer, Aristotelis Bamias, Matteo Santoni, Ithai Waldhorn

Read the full article. 

You can also read:

10 Bladder and Urothelial Cancer Trials to Watch at ESMO 2026

Francesco Massari: Excited to See Our ARON Research Published in Nature Communications

Alessandro Rizzo Aristotelis Bamias ARON project Avivit Peer Ayelet Alpert cancer Cristian Lolli Enrique Grande Fernando Sabino Marques Monteiro Francesco Ciccimarra Francesco Massari Giandomenico Roviello Hideki Takeshita Ithai Waldhorn Jalal Baranseh Joaquim Bellmunt Matteo Santoni Nectin-4 OncoDaily Oncology Ravindran Kanesvaran Sebastiano Buti Shilpa Gupta Tarek Taha urothelial cancer Yüksel Ürün